EA004256B1 - БЕЛОК, СВЯЗЫВАЮЩИЙСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ, КОДИРУЮЩИЙ ЕГО ПОЛИНУКЛЕОТИД И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ - Google Patents
БЕЛОК, СВЯЗЫВАЮЩИЙСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ, КОДИРУЮЩИЙ ЕГО ПОЛИНУКЛЕОТИД И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ Download PDFInfo
- Publication number
- EA004256B1 EA004256B1 EA199900941A EA199900941A EA004256B1 EA 004256 B1 EA004256 B1 EA 004256B1 EA 199900941 A EA199900941 A EA 199900941A EA 199900941 A EA199900941 A EA 199900941A EA 004256 B1 EA004256 B1 EA 004256B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- protein
- fragment
- cdna molecule
- sequence
- polynucleotide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6458397P | 1997-04-16 | 1997-04-16 | |
PCT/US1998/007462 WO1998046636A2 (en) | 1997-04-16 | 1998-04-14 | β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
Publications (2)
Publication Number | Publication Date |
---|---|
EA199900941A1 EA199900941A1 (ru) | 2000-06-26 |
EA004256B1 true EA004256B1 (ru) | 2004-02-26 |
Family
ID=22056941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199900941A EA004256B1 (ru) | 1997-04-16 | 1998-04-14 | БЕЛОК, СВЯЗЫВАЮЩИЙСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ, КОДИРУЮЩИЙ ЕГО ПОЛИНУКЛЕОТИД И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0975753A2 (xx) |
JP (3) | JP2001523093A (xx) |
KR (1) | KR20010006393A (xx) |
CN (2) | CN1690203A (xx) |
AU (1) | AU740445B2 (xx) |
BR (1) | BR9808562A (xx) |
CA (1) | CA2286484A1 (xx) |
EA (1) | EA004256B1 (xx) |
EE (1) | EE9900482A (xx) |
GE (1) | GEP20043386B (xx) |
HU (1) | HUP0003116A3 (xx) |
ID (1) | ID24914A (xx) |
IL (3) | IL132236A0 (xx) |
NO (1) | NO995062L (xx) |
NZ (1) | NZ500216A (xx) |
SK (1) | SK143299A3 (xx) |
UA (1) | UA72875C2 (xx) |
WO (1) | WO1998046636A2 (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005295B1 (en) | 1997-04-16 | 2006-02-28 | Wyeth | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
US6787319B2 (en) | 1997-04-16 | 2004-09-07 | American Home Products Corp. | β-amyloid peptide-binding proteins and polynucleotides encoding the same |
JP2002527064A (ja) * | 1998-10-13 | 2002-08-27 | アメリカン・ホーム・プロダクツ・コーポレイション | 6−蛋白結合受容体様蛋白、それらによりコードされるポリヌクレオチド、ならびにそれらの使用方法 |
US6455082B1 (en) * | 1999-04-26 | 2002-09-24 | Nestec S.A. | Shelf-stable calcium fortified milk and dairy products |
EP1226241A1 (en) * | 1999-10-21 | 2002-07-31 | Panorama Research, Inc. | A general method for optimizing the expression of heterologous proteins |
US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
US7807171B2 (en) | 2003-07-25 | 2010-10-05 | Ac Immune Sa | Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
WO2012020124A1 (en) | 2010-08-12 | 2012-02-16 | Ac Immune S.A. | Vaccine engineering |
CN103189050B (zh) | 2010-10-26 | 2017-09-29 | Ac免疫有限公司 | 包含通过疏水部分修饰的肽的基于脂质体的构建体 |
CN102060912B (zh) * | 2010-11-22 | 2012-11-14 | 清华大学 | 淀粉样蛋白寡聚体构象型抗原表位多肽及其应用 |
CN111320678B (zh) * | 2020-03-09 | 2023-06-09 | 安亭生物有限责任公司 | 抗菌肽突变体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988003951A1 (en) * | 1986-11-17 | 1988-06-02 | California Biotechnology, Inc. | Recombinant alzheimer's amyloid protein |
IL115743A0 (en) * | 1994-10-28 | 1996-01-19 | American Nat Red Cross | A mammal with cells containing a transgene and its production |
US5786180A (en) * | 1995-02-14 | 1998-07-28 | Bayer Corporation | Monoclonal antibody 369.2B specific for β A4 peptide |
-
1998
- 1998-04-14 CN CNA200510052975XA patent/CN1690203A/zh active Pending
- 1998-04-14 ID IDW991187D patent/ID24914A/id unknown
- 1998-04-14 GE GE3744A patent/GEP20043386B/en unknown
- 1998-04-14 BR BR9808562-0A patent/BR9808562A/pt not_active Application Discontinuation
- 1998-04-14 KR KR1019997009480A patent/KR20010006393A/ko not_active Application Discontinuation
- 1998-04-14 EA EA199900941A patent/EA004256B1/ru not_active IP Right Cessation
- 1998-04-14 CA CA002286484A patent/CA2286484A1/en not_active Abandoned
- 1998-04-14 EP EP98918186A patent/EP0975753A2/en not_active Withdrawn
- 1998-04-14 SK SK1432-99A patent/SK143299A3/sk unknown
- 1998-04-14 NZ NZ500216A patent/NZ500216A/xx unknown
- 1998-04-14 HU HU0003116A patent/HUP0003116A3/hu unknown
- 1998-04-14 IL IL13223698A patent/IL132236A0/xx active IP Right Grant
- 1998-04-14 UA UA99116193A patent/UA72875C2/uk unknown
- 1998-04-14 CN CNB988043173A patent/CN1196785C/zh not_active Expired - Fee Related
- 1998-04-14 JP JP54419698A patent/JP2001523093A/ja active Pending
- 1998-04-14 EE EEP199900482A patent/EE9900482A/xx unknown
- 1998-04-14 AU AU71156/98A patent/AU740445B2/en not_active Ceased
- 1998-04-14 WO PCT/US1998/007462 patent/WO1998046636A2/en active Application Filing
-
1999
- 1999-10-06 IL IL132236A patent/IL132236A/en not_active IP Right Cessation
- 1999-10-15 NO NO995062A patent/NO995062L/no not_active Application Discontinuation
-
2006
- 2006-11-05 IL IL179047A patent/IL179047A0/en unknown
-
2007
- 2007-12-28 JP JP2007339660A patent/JP2008104465A/ja active Pending
-
2008
- 2008-06-18 JP JP2008159606A patent/JP2008253275A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO995062L (no) | 1999-12-14 |
WO1998046636A3 (en) | 1999-01-28 |
KR20010006393A (ko) | 2001-01-26 |
JP2001523093A (ja) | 2001-11-20 |
HUP0003116A2 (hu) | 2001-01-29 |
CN1690203A (zh) | 2005-11-02 |
SK143299A3 (en) | 2000-09-12 |
ID24914A (id) | 2000-08-31 |
EE9900482A (xx) | 2000-06-15 |
JP2008104465A (ja) | 2008-05-08 |
UA72875C2 (uk) | 2005-05-16 |
IL179047A0 (en) | 2007-03-08 |
IL132236A (en) | 2007-03-08 |
BR9808562A (pt) | 2000-05-23 |
JP2008253275A (ja) | 2008-10-23 |
CA2286484A1 (en) | 1998-10-22 |
HUP0003116A3 (en) | 2003-03-28 |
AU7115698A (en) | 1998-11-11 |
AU740445B2 (en) | 2001-11-01 |
GEP20043386B (en) | 2004-02-10 |
NO995062D0 (no) | 1999-10-15 |
WO1998046636A2 (en) | 1998-10-22 |
CN1268973A (zh) | 2000-10-04 |
IL132236A0 (en) | 2001-03-19 |
CN1196785C (zh) | 2005-04-13 |
NZ500216A (en) | 2001-06-29 |
EP0975753A2 (en) | 2000-02-02 |
EA199900941A1 (ru) | 2000-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5562640B2 (ja) | ヒト固形腫瘍における遺伝子欠失及び突然変異alkキナーゼ | |
KR100499600B1 (ko) | 신생 세포 성장을 억제하기 위한 방법 및 조성물 | |
JP4260778B2 (ja) | 腫瘍の治療のための組成物と方法 | |
AU2003200722B2 (en) | Compositions and methods for the treatment of tumor | |
JP6144247B2 (ja) | ヒト非小細胞肺癌における転座および変異rosキナーゼ | |
EP1220905A2 (en) | Composition and methods for the treatment of immune related diseases | |
JP2002518010A (ja) | 94個のヒト分泌タンパク質 | |
EP1560597A2 (en) | Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same | |
JP2002533058A (ja) | 97個のヒト分泌タンパク質 | |
CA2378182C (en) | Compositions and methods for the treatment of tumors | |
JP2002506627A (ja) | 95個のヒト分泌タンパク質 | |
EA004256B1 (ru) | БЕЛОК, СВЯЗЫВАЮЩИЙСЯ С β-АМИЛОИДНЫМ ПЕПТИДОМ, КОДИРУЮЩИЙ ЕГО ПОЛИНУКЛЕОТИД И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ | |
KR20020008123A (ko) | 종양 치료용 조성물 및 방법 | |
KR20010103576A (ko) | 종양 치료용 조성물 및 치료 방법 | |
KR20010102960A (ko) | 종양 치료용 조성물 및 방법 | |
JP2000511765A (ja) | 精製SR―p70タンパク質 | |
WO2006082826A1 (ja) | Corl2遺伝子を標的としたプルキンエ細胞識別方法 | |
JP6740172B2 (ja) | ヒト固形腫瘍における遺伝子欠失及び突然変異alkキナーゼ | |
JP2002504361A (ja) | 36個のヒト分泌タンパク質 | |
WO2003102028A1 (fr) | Proteine induite par le gene rb1 (rb1cc1) et gene | |
AU776063C (en) | Compositions and methods for the treatment of tumor | |
WO2001005836A1 (en) | Polypeptidic compositions and methods for the treatment of tumors | |
JP6141224B2 (ja) | ヒト固形腫瘍における遺伝子欠失及び突然変異alkキナーゼ | |
KR20010102996A (ko) | 메그-4 단백질 | |
JP2020156481A (ja) | ヒト固形腫瘍における遺伝子欠失及び突然変異alkキナーゼ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |